|
Delayed
Hong Kong S.E.
13:22:51 24/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 22.78 HKD | -2.40% |
|
+3.72% | -25.07% |
| 07-31 | Medtide Names CFO | MT |
| 07-31 | Medtide Inc. Announces Appointment of Ding Lijun as Chief Financial Officer, Effective July 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 422M | - | - | |||
| 51.61B | |||||
| 44.89B | - | - | - | - | - |
| 42.77B | |||||
| 42.58B | |||||
| 31.82B |
- Stock Market
- Stocks
- 3880 Stock
- Charts Medtide Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
